TY - JOUR
T1 - Portopulmonary hypertension
T2 - A consequence of portal hypertension
AU - Krowka, Michael J.
AU - Rodriguez-Roisin, Roberto
PY - 2012
Y1 - 2012
N2 - Portopulmonary hypertension (POPH) is an uncommon pulmonary vascular consequence of portal hypertension. It presents as exertional dyspnoea andmay lead to right heart failure and death if untreated. There is no relationship between the existence and degree of POPH and the severity of advanced liver disease. Due to the spectrum of pulmonary haemodynamic changes associated with hepatic dysfunction, screening by transthoracic echocardiography and confirmation by right heart catheterisation (RHC) is necessary for accurate diagnosis and therapeutic considerations. Despite the lack of controlled studies, pulmonary vasomodulation therapies in POPH can significantly improve pulmonary haemodynamics and right ventricular (RV) function. The potential to "cure" POPH, at least haemodynamically, with a combination of pulmonary vasomodulation therapy and liver transplantation appears to be an attainable goal in a cohort of POPH patients yet to be optimally characterised. Controlled, multicentre studies and long-term follow-up post-liver transplantation are needed.
AB - Portopulmonary hypertension (POPH) is an uncommon pulmonary vascular consequence of portal hypertension. It presents as exertional dyspnoea andmay lead to right heart failure and death if untreated. There is no relationship between the existence and degree of POPH and the severity of advanced liver disease. Due to the spectrum of pulmonary haemodynamic changes associated with hepatic dysfunction, screening by transthoracic echocardiography and confirmation by right heart catheterisation (RHC) is necessary for accurate diagnosis and therapeutic considerations. Despite the lack of controlled studies, pulmonary vasomodulation therapies in POPH can significantly improve pulmonary haemodynamics and right ventricular (RV) function. The potential to "cure" POPH, at least haemodynamically, with a combination of pulmonary vasomodulation therapy and liver transplantation appears to be an attainable goal in a cohort of POPH patients yet to be optimally characterised. Controlled, multicentre studies and long-term follow-up post-liver transplantation are needed.
KW - Echocardiography
KW - Liver transplant
KW - Right heart catheterisation
UR - http://www.scopus.com/inward/record.url?scp=84865604774&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84865604774&partnerID=8YFLogxK
U2 - 10.1183/1025448x.10018811
DO - 10.1183/1025448x.10018811
M3 - Article
AN - SCOPUS:84865604774
SN - 1025-448X
VL - 57
SP - 58
EP - 70
JO - European Respiratory Monograph
JF - European Respiratory Monograph
ER -